CN1313818C - Method for detecting phosphate radical in urine - Google Patents
Method for detecting phosphate radical in urine Download PDFInfo
- Publication number
- CN1313818C CN1313818C CNB2004100124481A CN200410012448A CN1313818C CN 1313818 C CN1313818 C CN 1313818C CN B2004100124481 A CNB2004100124481 A CN B2004100124481A CN 200410012448 A CN200410012448 A CN 200410012448A CN 1313818 C CN1313818 C CN 1313818C
- Authority
- CN
- China
- Prior art keywords
- urine
- solution
- phosphate
- cuvette
- phosphate radical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000002700 urine Anatomy 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims abstract description 20
- 229910019142 PO4 Inorganic materials 0.000 title claims description 41
- 239000010452 phosphate Substances 0.000 title claims description 41
- 239000000243 solution Substances 0.000 claims abstract description 44
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000007995 HEPES buffer Substances 0.000 claims abstract description 9
- 238000010521 absorption reaction Methods 0.000 claims description 23
- 238000001514 detection method Methods 0.000 claims description 7
- HGPSVOAVAYJEIJ-XDHOZWIPSA-N 2-[(e)-(3,4-dihydroxyphenyl)-(3-hydroxy-4-oxoniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonate Chemical compound C1=CC(=O)C(O)=C\C1=C(C=1C(=CC=CC=1)S(O)(=O)=O)/C1=CC=C(O)C(O)=C1 HGPSVOAVAYJEIJ-XDHOZWIPSA-N 0.000 claims description 5
- 229910020366 ClO 4 Inorganic materials 0.000 claims description 3
- 241001062009 Indigofera Species 0.000 claims 1
- RRRCKIRSVQAAAS-UHFFFAOYSA-N 4-[3-(3,4-dihydroxyphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]benzene-1,2-diol Chemical compound C1=C(O)C(O)=CC=C1C1(C=2C=C(O)C(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 RRRCKIRSVQAAAS-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052769 Ytterbium Inorganic materials 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- -1 ytterbium ions Chemical class 0.000 abstract description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 25
- 238000010586 diagram Methods 0.000 description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229910003317 GdCl3 Inorganic materials 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 241001177854 Oplitis Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038419 Renal colic Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- MXZRMHIULZDAKC-UHFFFAOYSA-L ammonium magnesium phosphate Chemical compound [NH4+].[Mg+2].[O-]P([O-])([O-])=O MXZRMHIULZDAKC-UHFFFAOYSA-L 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HDGGAKOVUDZYES-UHFFFAOYSA-K erbium(iii) chloride Chemical compound Cl[Er](Cl)Cl HDGGAKOVUDZYES-UHFFFAOYSA-K 0.000 description 1
- MEANOSLIBWSCIT-UHFFFAOYSA-K gadolinium trichloride Chemical compound Cl[Gd](Cl)Cl MEANOSLIBWSCIT-UHFFFAOYSA-K 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 235000020938 metabolic status Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明使用镱离子、以邻苯二酚紫为显色剂在pH为7.0左右的HEPES缓冲溶液定性、定量的去直接测定未稀释人体尿液中磷酸很的含量,测定过程简单,方便,测量结果准确。此方法灵敏度高,而且不受尿液中其它成份的干扰,可以应用于临床。The present invention uses ytterbium ions, catechol violet as a chromogen, and a HEPES buffer solution with a pH of about 7.0 to qualitatively and quantitatively directly measure the content of phosphoric acid in undiluted human urine. The determination process is simple, convenient, and easy to measure. The result is accurate. This method has high sensitivity and is not interfered by other components in urine, so it can be applied clinically.
Description
技术领域:Technical field:
本发明涉及一种磷酸根的检测方法,具体属于一种检测尿液中磷酸根的方法。The invention relates to a method for detecting phosphate radicals, in particular to a method for detecting phosphate radicals in urine.
背景技术:Background technique:
磷酸根参与各种重要的生物矿化过程,诸如骨骼的形成以及肾结石的起源等病理过程。因此,生物液体中磷酸根的检测是很重要的。我们知道尿液在临床事件中有很重要的诊断价值,所以检测人体尿液中自由的磷酸根离子是很有必要的。科学上的研究结果表明:尿液中含有过多的磷酸镁铵,碳酸磷灰石,羟基磷灰石,二水磷酸氢钙,磷酸三钙等晶体属于造成尿结石的原因之一。我们知道结石病伴随有许多痛苦比如肾绞痛,恶心呕吐,血尿,发热等,甚至引起更大的其它疾病。因此维持尿液中一定浓度的磷酸根很关键。由此看来定期的定量测定尿液中的磷酸根是必不可少的。我们可以通过定期测量尿液中的磷酸根的含量,了解生物体的代谢状况及有关病变状态。Phosphate is involved in various important biomineralization processes, such as bone formation and pathological processes such as the origin of kidney stones. Therefore, the detection of phosphate in biological fluids is important. We know that urine has a very important diagnostic value in clinical events, so it is necessary to detect free phosphate ions in human urine. Scientific research results show that excessive magnesium ammonium phosphate, carbonate apatite, hydroxyapatite, calcium hydrogen phosphate dihydrate, tricalcium phosphate and other crystals in urine are one of the causes of urinary stones. We know that stone disease is accompanied by many pains such as renal colic, nausea and vomiting, hematuria, fever, etc., and even causes other diseases. Therefore, it is critical to maintain a certain concentration of phosphate in the urine. From this point of view, regular quantitative determination of phosphate in urine is essential. We can know the metabolic status of the organism and related pathological conditions by regularly measuring the content of phosphate radicals in the urine.
关于测定尿液中的磷酸根,以往国内外对检测尿液中的磷酸根的方法可归纳为以下几种:Regarding the determination of phosphate radicals in urine, the methods for detecting phosphate radicals in urine at home and abroad in the past can be summarized as the following:
1、使用离子色谱检测尿液中的磷酸根(L.Opliti,R.Chiaraluce,V.Consalvi,N.Cetulli and R.Scandurra,Clinica Chimica Acta,184(1989)155-166;Journal ofChromatography,433(1988)373-376;1. Use ion chromatography to detect phosphate radicals in urine (L.Opliti, R.Chiaraluce, V.Consalvi, N.Cetulli and R.Scandurra, Clinica Chimica Acta, 184 (1989) 155-166; Journal of Chromatography, 433( 1988) 373-376;
2、基于磷酸根对碳酸钙晶种的强烈抑制,来测定尿液中的磷酸根(F.Grases andJ.G.March,Analytica Chimica Acta,229(1990)249-254);2. Determination of phosphate in urine based on the strong inhibition of phosphate on calcium carbonate seeds (F. Grases and J.G. March, Analytica Chimica Acta, 229 (1990) 249-254);
3、使用单一的在线校准法和光度测定法通过序列注射分析测定尿液中的磷酸根(D.G.Themelis,A.Economou,a.Tsiomlektsis and p.D.Tzanavaras,AnalyticalBiochemistry 330(2004)193-198)。3. Determination of phosphate in urine by sequential injection analysis using a single on-line calibration and photometry (D.G.Themelis, A.Economou, a.Tsiomlektsis and p.D.Tzanavaras, Analytical Biochemistry 330(2004) 193-198).
但以上的这些方法分别存在一些问题:However, there are some problems with the above methods:
1、许多仪器在临床上测量尿液中的磷酸根由于窄的线性范围,需要很大程度的稀释尿样,才能去测量。1. Many instruments are clinically used to measure phosphate in urine due to the narrow linear range, which requires a large degree of dilution of urine samples to measure.
2、许多测量尿液中的磷酸根的方法是通过测尿中的其它某些成份来间接的测量的。比如通过测尿石的碳酸钙晶体生长来确定磷酸根的含量。这样既繁琐,又费工费时,在临床上带来许多不便。2. Many methods of measuring phosphate in urine are measured indirectly by measuring some other components in urine. For example, the phosphate content can be determined by measuring the growth of calcium carbonate crystals in uroliths. This is both cumbersome and time-consuming, which brings a lot of inconvenience clinically.
3、许多检测尿液中磷酸根的方法,灵敏度较低,偏差较大,或者给不出一个准确定量的结果。3. Many methods for detecting phosphate in urine have low sensitivity, large deviation, or cannot give an accurate quantitative result.
发明内容:Invention content:
本发明的目的在于突破以往传统的检测尿液中磷酸根的方法,发明一种简单、灵敏、快速的,临床上可以使用的,检测未稀释尿液中磷酸根的方法。The purpose of the present invention is to break through the previous traditional method for detecting phosphate in urine, and to invent a simple, sensitive, rapid and clinically applicable method for detecting phosphate in undiluted urine.
本发明提供一种检测尿液中磷酸根的方法,该方法基于镱离子、以邻苯二酚紫为显色剂在pH为6.5-7.5的HEPES缓冲溶液中直接并定量地检测尿液中的磷酸根,其具体检测步骤如下:The invention provides a method for detecting phosphate in urine, which is based on ytterbium ions, and uses catechol violet as a color reagent to directly and quantitatively detect phosphate in urine in a HEPES buffer solution with a pH of 6.5-7.5. Phosphate, the specific detection steps are as follows:
1、配制pH6.5-7.5的HEPES(10mM)缓冲溶液,并配制2×10-3M的Yb3+溶液和2×10-3M的邻苯二酚紫溶液;1. Prepare a HEPES (10mM) buffer solution with a pH of 6.5-7.5, and prepare 2×10 -3 M Yb 3+ solution and 2×10 -3 M catechol violet solution;
2、把2ml的HEPES缓冲溶液加到干净的紫外比色皿中,作为空白,用微量进样器吸取2×10-3M的邻苯二酚紫溶液10-100μl,加到此比色皿中,此时溶液由无色变黄,在紫外可见分光光度仪上检测,443nm有最大吸收;2. Add 2ml of HEPES buffer solution to a clean UV cuvette, as a blank, use a micro-sampler to absorb 10-100μl of 2×10 -3 M catechol violet solution, and add it to this cuvette At this time, the solution turns from colorless to yellow, and it is detected on a UV-visible spectrophotometer, and there is a maximum absorption at 443nm;
3、在上述的比色皿中,加入摩尔数2倍于邻苯二酚紫溶液的Yb3+溶液,此时溶液由黄变蓝,在紫外可见分光光度仪上检测,发现最大吸收峰由上述的443nm变为623nm;3. In the above-mentioned cuvette, add the Yb 3+ solution whose molar number is 2 times that of the pyrocatechol violet solution. At this moment, the solution turns from yellow to blue, and detects on a UV-Vis spectrophotometer, and finds that the maximum absorption peak is formed by The above 443nm becomes 623nm;
4、取尿样,逐渐用微量进样器加到此比色皿中,边加样边在紫外可见分光光度仪上检测,随着尿样的加入,最大吸收峰又由623nm逐渐向443nm变回,溶液的颜色也逐渐由蓝变回黄色,当吸收峰在443nm达到最大,溶液的颜色完全变黄时,停止加尿样;4. Take a urine sample, gradually add it to the cuvette with a micro-injector, and detect it on the UV-Vis spectrophotometer while adding the sample. With the addition of the urine sample, the maximum absorption peak gradually changes from 623nm to 443nm The color of the solution also gradually changed from blue to yellow. When the absorption peak reached its maximum at 443nm and the color of the solution turned yellow completely, stop adding urine samples;
5、按[Yb3+]×2ml×95/m尿×100%计算出尿液中磷酸根得含量,式中m尿=V尿。5. Calculate the phosphate radical content in urine according to [Yb 3+ ]×2ml×95/m urine ×100%, where m urine =V urine .
所述的Yb3+溶液是YbCl3溶液或Yb(ClO4)3的溶液。The Yb 3+ solution is a YbCl 3 solution or a Yb(ClO 4 ) 3 solution.
所述的Yb3+可以用Nd3+、Sm3+、Gd3+、Er3+或Ho3+代替。The Yb 3+ can be replaced by Nd 3+ , Sm 3+ , Gd 3+ , Er 3+ or Ho 3+ .
本发明具有如下优点:1、我们的检测对象是未稀释的尿样,省去预处理程序,在临床上带来很大的很方便;2、在紫外可见分光光度仪上检测,检测过程简单,而且可以用肉眼明显观察到此效应;3、尽管尿液中含有许多其它成份,但我们的检测方法,对磷酸根显示了很好的选择性,也就是说,其它成份的存在并不干扰我们的检测结果;4、我们的检测是定量的,有很大的线性范围,而且误差很小;显然,此发明可以应用到临床上检测尿样。The present invention has the following advantages: 1, our detection object is the undiluted urine sample, saves the pretreatment procedure, brings very big convenience clinically; 2, detects on the ultraviolet-visible spectrophotometer, and the detection process is simple , and this effect can be clearly observed with the naked eye; 3. Although there are many other components in urine, our detection method shows good selectivity for phosphate, that is to say, the presence of other components does not interfere Our detection results; 4. Our detection is quantitative, has a large linear range, and the error is very small; obviously, this invention can be applied to clinically detect urine samples.
附图说明:Description of drawings:
图1至图9是相应实施例1至实施例9的检测尿液中磷酸根的紫外可见吸收图。Figures 1 to 9 are UV-visible absorption diagrams for detecting phosphate radicals in urine corresponding to Examples 1 to 9.
具体实施方式:Detailed ways:
实施例1.配制pH7.0的HEPES(10mM)缓冲溶液,并配制2×10-3M的YbCl3溶液和2×10-3M的邻苯二酚紫溶液;把2ml的HEPES缓冲溶液加到干净的紫外比色皿中,作为空白,用微量进样器吸取2×10-3M的邻苯二酚紫溶液50μl,加到此比色皿中,此时溶液由无色变黄,在HP8453紫外可见分光光度仪上检测,443nm有最大吸收;在上述的比色皿中,加入2×10-3M的Yb3+溶液100μl,此时溶液由黄变蓝,在紫外可见分光光度仪上检测,发现最大吸收峰由上述的443nm变为623nm;取成人尿样,逐渐用微量进样器加到此比色皿中,边加样边在紫外可见分光光度仪上检测,随着尿样的加入,最大吸收峰又由623nm逐渐向443nm变回,溶液的颜色也逐渐由蓝变回黄色,当吸收峰在443nm达到最大,溶液的颜色完全变黄时,此时尿液加入量为20μl;计算:100μl×2ml×95/20g×100%,得尿液中磷酸根含量为0.095%,紫外可见吸收图见图1。Embodiment 1. prepare the HEPES (10mM) buffer solution of pH7.0, and prepare the YbCl 3 solution of 2×10 -3 M and the pyrocatechol violet solution of 2×10 -3 M; Add the HEPES buffer solution of 2ml Put it into a clean ultraviolet cuvette, as a blank, draw 50 μl of 2×10 -3 M catechol violet solution with a micro-injector, add it to this cuvette, at this time, the solution turns from colorless to yellow, Detected on the HP8453 UV-Vis spectrophotometer, there is a maximum absorption at 443nm; in the above-mentioned cuvette, add 100 μl of 2×10 -3 M Yb 3+ solution, at this time, the solution turns from yellow to blue. It was detected on the instrument, and it was found that the maximum absorption peak changed from the above-mentioned 443nm to 623nm; adult urine samples were taken, gradually added to the cuvette with a micro-injector, and detected on the UV-Vis spectrophotometer while adding samples, as When the urine sample is added, the maximum absorption peak gradually changes from 623nm to 443nm, and the color of the solution gradually changes from blue to yellow. When the absorption peak reaches the maximum at 443nm and the color of the solution turns yellow completely, the amount of urine added It is 20 μl; calculation: 100 μl×2ml×95/20g×100%, the phosphate content in urine is 0.095%, and the ultraviolet-visible absorption diagram is shown in Figure 1.
按实施例1测10个健康成人尿样,得尿液中磷酸根含量为0.0863-0.119%。如果按成人24小时尿液的排出量为1L,那么得出成人尿中无机磷酸盐的排出量范围为0.863-1.19g,与医学上尿中统计的无机磷酸盐的正常排出量(0.5~1.5g/24小时)稳合。Test 10 healthy adult urine samples according to Example 1, and the phosphate content in the urine is 0.0863-0.119%. If the 24-hour urine output of an adult is 1L, the range of inorganic phosphate excretion in adult urine is 0.863-1.19g, which is the same as the normal excretion of inorganic phosphate in urine (0.5-1.5g) in medical statistics. g/24 hours) are stable.
实施例2.配制pH6.5的HEPES(10mM)缓冲溶液,其余同实施例1,得尿液中磷酸根含量为0.095%,紫外可见吸收图见图2。Embodiment 2. prepare the HEPES (10mM) buffer solution of pH6.5, all the other are the same as embodiment 1, the phosphate radical content is 0.095% in the urine, and the ultraviolet-visible absorption diagram is shown in Fig. 2.
实施例3.取一周岁健康小孩尿液,其余同实施例1,计算:100μl×2ml×95/4g×100%,得尿液中磷酸根含量为0.38%,紫外可见吸收图见图3。从上述实施例中,我们看出小孩尿液中的磷酸根含量偏高,这是因为小孩与大人相比而言,由于小孩处于成骨旺盛期,碱性磷酸酶活性较高以及代谢速度相当快等原因所造成。Embodiment 3. Get one-year-old healthy child urine, all the other are the same as embodiment 1, calculate: 100 μ l * 2ml * 95/4g * 100%, the phosphate radical content is 0.38% in the urine, and the ultraviolet-visible absorption figure is shown in Fig. 3. From the above examples, we can see that the content of phosphate in children's urine is relatively high. This is because compared with adults, children have higher alkaline phosphatase activity and similar metabolic rate due to the fact that children are in the period of vigorous osteogenesis. Wait for the reason.
实施例4.用Yb(ClO4)3的溶液,取另一成人的尿液,其余同实施例1,100μl×2ml×95/16g×100%,得尿液中磷酸根含量为0.119%,紫外可见吸收图见图4。Embodiment 4. use the solution of Yb(ClO 4 ) 3 to get the urine of another adult, and all the other are the same as in Example 1, 100 μl × 2ml × 95/16g × 100%, so that the phosphate content in the urine is 0.119%. The UV-Vis absorption diagram is shown in Figure 4.
实施例5.用ErCl3的溶液,其余其余同实施例1,100μl×2ml×95/20g×100%,得尿液中磷酸根含量为0.095%,紫外可见吸收图见图5。Embodiment 5. use the solution of ErCl3 , all the other are the same as
实施例6.用NdClO4)3的溶液,其余同实施例1,100μl×2ml×95/20g×100%,得尿液中磷酸根含量为0.095%,紫外可见吸收图见图6。Example 6. Use the solution of NdClO 4 ) 3 , the rest are the same as in Example 1, 100 μl×2ml×95/20g×100%, the phosphate content in the urine is 0.095%, and the ultraviolet-visible absorption diagram is shown in Figure 6.
实施例7.用SmClO4)3的溶液,其余同实施例l,100μl×2ml×95/20g×100%,得尿液中磷酸根含量为0.095%,紫外可见吸收图见图7。Example 7. Use the solution of SmClO 4 ) 3 , the rest are the same as in Example 1, 100 μl×2ml×95/20g×100%, the phosphate content in the urine is 0.095%, and the UV-visible absorption diagram is shown in Figure 7.
实施例8.用GdCl3的溶液,其余同实施例l,100μl×2ml×95/16g×100%,得尿液中磷酸根含量为0.095%,紫外可见吸收图见图8。Embodiment 8. Use the solution of GdCl3 , all the other are with
实施例9.用HoCl3的溶液,其余同实施例1,100μl×2ml×95/16g×100%,得尿液中磷酸根含量为0.095%,紫外可见吸收图见图9。Example 9. Use the solution of HoCl3 , the rest are the same as in Example 1, 100 μl × 2ml × 95/16g × 100%, the phosphate content in the urine is 0.095%, and the UV-visible absorption diagram is shown in Figure 9.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100124481A CN1313818C (en) | 2004-07-26 | 2004-07-26 | Method for detecting phosphate radical in urine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100124481A CN1313818C (en) | 2004-07-26 | 2004-07-26 | Method for detecting phosphate radical in urine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1598539A CN1598539A (en) | 2005-03-23 |
| CN1313818C true CN1313818C (en) | 2007-05-02 |
Family
ID=34662805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100124481A Expired - Fee Related CN1313818C (en) | 2004-07-26 | 2004-07-26 | Method for detecting phosphate radical in urine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1313818C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100594373C (en) * | 2008-04-25 | 2010-03-17 | 山西大学 | Method for detecting aqueous solution oxalate |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1317564C (en) * | 2005-04-08 | 2007-05-23 | 山西大学 | Method for visual detection of inorganic phosphorus in urine and kit thereof |
| CN104267029B (en) * | 2014-10-23 | 2017-05-17 | 攀枝花钢企欣宇化工有限公司 | Quantitative analysis method for phosphate radical |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5991367A (en) * | 1982-11-16 | 1984-05-26 | Fuaintetsuku Japan:Kk | Highly sensitive analysis of phosphate ion |
| US5117370A (en) * | 1988-12-22 | 1992-05-26 | Ford Motor Company | Detection system for chemical analysis of zinc phosphate coating solutions |
| CN2288442Y (en) * | 1997-03-31 | 1998-08-19 | 陈义新 | Automatic detector for phosphate content in water |
| CN1044744C (en) * | 1996-11-15 | 1999-08-18 | 衡水市环境保护局 | Preparation method for phosphorus indicator paper |
-
2004
- 2004-07-26 CN CNB2004100124481A patent/CN1313818C/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5991367A (en) * | 1982-11-16 | 1984-05-26 | Fuaintetsuku Japan:Kk | Highly sensitive analysis of phosphate ion |
| US5117370A (en) * | 1988-12-22 | 1992-05-26 | Ford Motor Company | Detection system for chemical analysis of zinc phosphate coating solutions |
| CN1044744C (en) * | 1996-11-15 | 1999-08-18 | 衡水市环境保护局 | Preparation method for phosphorus indicator paper |
| CN2288442Y (en) * | 1997-03-31 | 1998-08-19 | 陈义新 | Automatic detector for phosphate content in water |
Non-Patent Citations (4)
| Title |
|---|
| 氧化铝微柱预富集分光光度法测定天然水体中微量磷酸根 丁建华等,分析科学学报,第18卷第3期 2002 * |
| 焦磷酸铜镀液中磷酸根和焦磷酸根的光度测定 邱星初等,材料保护,第33卷第12期 2000 * |
| 焦磷酸铜镀液中磷酸根和焦磷酸根的光度测定 邱星初等,材料保护,第33卷第12期 2000;饲料中无机磷和有机磷的测定方法 钟国清,饲料检测,第24卷第7期 2003;氧化铝微柱预富集分光光度法测定天然水体中微量磷酸根 丁建华等,分析科学学报,第18卷第3期 2002 * |
| 饲料中无机磷和有机磷的测定方法 钟国清,饲料检测,第24卷第7期 2003 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100594373C (en) * | 2008-04-25 | 2010-03-17 | 山西大学 | Method for detecting aqueous solution oxalate |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1598539A (en) | 2005-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Robertson et al. | Calcium measurements in serum and plasma—total and ionized | |
| JP4515786B2 (en) | Method for reducing the influence of hematocrit on the measurement of an analyte in whole blood, and a test kit and a test article useful in the method | |
| Morin | Direct colorimetric determination of serum calcium with o-cresolphthalein complexon | |
| KR20160018479A (en) | Method and kits for the diagnosis of influenza | |
| EP2029768B1 (en) | Method of determining thrombin activity in plasma | |
| WO2010141719A2 (en) | Materials and methods for measuring nitric oxide levels in a biological fluid | |
| March et al. | Determination of pyrophosphate in renal calculi and urine by means of an enzymatic method | |
| CN107703112B (en) | Ratiometric fluorescence detection of heparin sodium based on fluorescently labeled DNA quenched by carbon quantum dots | |
| US20130302781A1 (en) | Analyte detection method | |
| CN1313818C (en) | Method for detecting phosphate radical in urine | |
| Wang et al. | Auto recalibration based on dual-mode sensing for robust optical continuous glucose monitoring | |
| Bäck et al. | A simple chemical method for the quantification of the contrast agent iohexol, applicable to glomerular filtration rate measurements | |
| Srivastava et al. | Effect of caffeine on the possible amelioration of diabetic neuropathy: A spectroscopic study | |
| ITTO990882A1 (en) | PROCEDURE AND DEVICE FOR DETERMINING THE CONCENTRATION OF HEPARIN IN A FLUID SAMPLE. | |
| Ganter et al. | Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients | |
| Colombi et al. | Low-pH method for the enzymatic assay of D-glucaric acid in urine | |
| US5695929A (en) | Substitute saliva standard | |
| CN1317564C (en) | Method for visual detection of inorganic phosphorus in urine and kit thereof | |
| US20020098591A1 (en) | Rapid assay for testing overall oxidative stress | |
| US20070196927A1 (en) | Method For Qualitative And/Or Quantitative Detection Of Polyethylene Glycols In Biological Fluids | |
| Abernethy et al. | Plasma cholinesterase phenotyping with use of visible-region spectrophotometry. | |
| CA1255210A (en) | Method of determining periodontal disease | |
| RU2804417C1 (en) | Method for quantitative fluorometric determination of 2-ethyl-6-methyl-hydroxypyridine hydrochloride | |
| Borland et al. | A fast automated method for measuring serum and urine citrate | |
| RU2034299C1 (en) | Method for diagnostics of trend in multiple sclerosis course |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070502 |